'학술논문' 에서의 검색결과 67건 | 목록 1~10
-
1. ARTICLEMetabolism of MMB022 and identification of dihydrodiol formation in vitro using synthesized standards
- In: Drug Testing and Analysis. (Drug Testing and Analysis, 1 October 2020, 12(10):1432-1441)
-
2. ARTICLEThe influence of ABCG2 polymorphism on erlotinib efflux in the K562 cell line
- In: Pharmacology Research and Perspectives. (Pharmacology Research and Perspectives, 1 April 2020, 8(2))
-
3. ARTICLEMetabolite Profiling of Ortho-, Meta- And Para-Fluorofentanyl by Hepatocytes and High-Resolution Mass Spectrometry
- In: Journal of Analytical Toxicology. (Journal of Analytical Toxicology, 2 August 2019, 44(2):140-148)
-
4. ARTICLEFemoral blood concentrations of flualprazolam in 33 postmortem cases
- In: Forensic Science International. (Forensic Science International, February 2020, 307)
-
5. ARTICLEActivation of the μ-opioid receptor by alicyclic fentanyls: Changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure
- In: Drug Testing and Analysis. (Drug Testing and Analysis, 2020)
-
6. ARTICLEBiotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood
- In: AAPS Journal. (AAPS Journal, 1 January 2020, 22(1))
-
7. ARTICLEMetabolism of the benzodiazepines norflurazepam, flurazepam, fludiazepam and cinolazepam by human hepatocytes using high-resolution mass spectrometry and distinguishing their intake in authentic urine samples
- In: Forensic Toxicology. (Forensic Toxicology, 1 January 2020, 38(1):79-94)
-
8. ARTICLE5F-MDMB-PICA metabolite identification and cannabinoid receptor activity
- In: Drug Testing and Analysis. (Drug Testing and Analysis, 1 January 2020, 12(1):127-135)
-
9. ARTICLELC-QTOF-MS identification of major urinary cyclopropylfentanyl metabolites using synthesized standards
- In: Journal of Analytical Toxicology. (Journal of Analytical Toxicology, 19 August 2019, 43(8):607-614)
-
10. ARTICLEErlotinib treatment induces cytochrome P450 3A activity in non-small cell lung cancer patients
- In: British Journal of Clinical Pharmacology. (British Journal of Clinical Pharmacology, August 2019, 85(8):1704-1709)